BioSpace News Archive

First to demonstrate deep learning algorithm can be trained to automatically predict levels of ulcerative colitis severity from endoscopic videos

Fabric Genomics, a global leader in clinical interpretation of genomic data, announced today the launch of Fabric GEM, a novel algorithm that quickly and efficiently identifies the likely genetic cause of rare diseases from next-generation sequencing data – enabling faster diagnosis and the possibility of faster and more effective treatment.

Health Canada is advising Canadians that the following products may pose serious health risks.

Oxford Immunotec Global PLC (Nasdaq:OXFD) (the “Company”), a global, high-growth diagnostics company, today announced that it plans to release third quarter 2020 financial results before the open of the market on Tuesday, November 3, 2020.

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report third quarter results on November 4, 2020 at 4:00 PM Eastern Time.

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care, today announced that the Company’s WristMotion Total Arthroplasty System received 510(k) clearance from the U.S. Food and Drug Administration.

Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) announced the results of its rights offering following the expiration of the subscription period on October 9, 2020 at 5:00 p.m. New York City Time.

Avantor, Inc. announced that its Board of Directors has declared a quarterly cash dividend to holders of its 6.250% Series A Mandatory Convertible Preferred Stock of $0.78 per share at a rate per share of 1.560%, payable on November 15, 2020 to holders of record on November 1, 2020.

Cancer immunotherapy has emerged as a new avenue for revenue generation for pharmaceutical companies.

RetinalGeniX ™ Technologies, Inc. https://retinalgenix.com/ announced today that it has awarded a contract to Plan Management Corporation (PMC) for use of their OPTIONTRAX Equity Plan and Cap Table Software. RetinalGeniX ™ Technologies is a private California -based medical technology company focused on prevention of bli